Methods and apparatus for accessing and treating the facet joint

Information

  • Patent Grant
  • 9005288
  • Patent Number
    9,005,288
  • Date Filed
    Thursday, January 8, 2009
    15 years ago
  • Date Issued
    Tuesday, April 14, 2015
    9 years ago
Abstract
Methods and systems are disclosed for accessing and treating the interior of the facet joint for vertebral distraction and immobilization. The systems include a number of tools that facilitate access to the facet joint, distraction of the articulating decortication of the articulating surfaces, and delivery of implants and agents into the facet joint for fusion.
Description
FIELD OF THE INVENTION

This invention pertains generally to treatment of the facet joint, and more particularly to tools and methods for accessing, preparing and facilitating spinal distraction.


BACKGROUND

Neck and arm pain is a common ailment of the aging spine due to disc herniations, facet arthropathy and thickening of spinal ligaments which narrow spinal canal dimensions. This results in compression of the spinal cord or nerve roots, or both. Radicular pain is typically due to disc herniation and foraminal narrowing, which compresses the cervical nerve roots and causes radicular pain. Extension and ipsilateral rotation of the neck further reduces the foraminal area and contributes to pain, nerve root compression, and neural injury. Neck flexion generally increases the foraminal area.


Cervical disc herniations and foraminal stenosis typically present with upper extremity radicular pain without major motor or sensory neurologic deficit. A well-described treatment for cervical disc herniations is closed traction. There are a number of marketed devices that alleviate pain by pulling on the head to increase foraminal height.


Cervical disc herniations have been treated with anterior and posterior surgery. The vast majority are performed through an anterior surgical approach, which entails a spinal fusion. These surgeries are expensive and beget additional surgeries due to change in biomechanics of the neck. There is a 3% incidence of re-operation per year that is cumulative at adjacent levels.


There is a need in the art for minimally invasive methods and devices for accessing and preparing and distracting the facet joint to increase foraminal height and reduce radicular symptoms for patients with soft and hard disc disease.


SUMMARY

Devices and techniques are disclosed for a percutaneous or minimally invasive surgical implantation to reduce radicular symptoms by inserting an expandable cervical distraction implant in the facet joint at a symptomatic level to decompress the nerve tissue and preserve motion. In particular, embodiments of the present invention provide for accessing and distracting the cervical facet to increase the foraminal dimension. In one embodiment, the implant of the present invention, when positioned in the cervical facet joint, increases the space between the articular facets, to increase the foraminal area or dimension, and reduce pressure on the nerve and associated blood vessels.


The procedure may be performed under conscious sedation in order to obtain intra-operative patient symptom feedback.


An aspect of an embodiment of the invention is an apparatus for accessing an interior region of a facet joint, comprising an elongate handle having a proximal end and a distal end, and a blade disposed at the distal end of the handle. The blade may have a flat leading edge such that placement of the blade through the facet capsule and into the facet cavity to generate a slit-shaped aperture in the facet capsule. Preferably, the aperture may extend substantially parallel to the first and second articulating subchondral surfaces.


In one embodiment, the blade comprises a planar lower surface extending from the leading edge, and extending proximally away from the leading edge, wherein the planar surface provides a platform to guide a second instrument through the aperture for treatment of the facet joint.


In one mode of the current embodiment, the blade comprises an upper surface opposite the lower surface, with the upper surface and lower surface defining a thickness, generally sized to be smaller than the distance between the first and second boundaries of a facet cavity.


Preferably, in one embodiment, a beveled surface emanates from the upper blade surface and extends proximally away from the leading edge. Accordingly, the thickness increases proximally along the beveled surface. The beveled surface generally facilitates manipulation of the blade into the cavity.


In one embodiment, the handle comprises a shaft extending from the distal end to the proximal end, wherein the shaft comprises a beveled surface emanating at or near the leading edge and extending proximally away from the leading edge. The beveled surface facilitates insertion of the blade into the cavity at an angle not aligned with the first and second cavity boundaries.


In another embodiment, the shaft is disposed within a central channel running along the length of the handle, and extends from the distal end of the handle. The shaft may have a D-shaped cross section providing a flat planar surface in cooperation with the blade.


Another aspect of an embodiment is an apparatus for decorticating an interior region of a facet joint, comprising an elongate handle having a proximal end and a distal end, and a rasp configured to decorticate a at least one of the articulating subchondral surfaces. The rasp may have a roughened planar surface extending distally outward from the distal end of the handle, and may be generally spatula-shaped and sized to be delivered into the facet joint via an aperture in the joint capsule and oriented in the joint substantially in line with the plane of the facet joint articulating surfaces. Generally the rasp comprises a compliant, thin cross section that allows the rasp to bend while being delivered into the facet from an angle out of alignment with the plane of the facet joint articulating surfaces.


The blade may have substantially planar lower surface extending from the leading edge, and extend proximally away from the leading edge. This planar surface may provide a platform for guiding the rasp in cooperation with a second instrument through the aperture for treatment of the facet joint.


In another embodiment, the rasp comprises an upper roughened surface opposite and substantially parallel with the lower surface, wherein the thickness is sized to be smaller than the distance between the first and second boundaries of a facet cavity, and to dispose the rasp to bending under light to moderate pressure. A beveled surface may emanate from the upper surface at a point proximal from a leading edge of the rasp and extending proximally away from the leading edge.


Another aspect of an embodiment is an apparatus for accessing an interior region of a facet joint, comprising an elongate handle having a proximal end and a distal end, and a spatula-shaped tip disposed at the distal end of the handle, with the tip comprising upper and lower parallel planar surface extending distally outward from the distal end of the handle. The tip may be sized to be delivered into the facet joint via an aperture in the joint capsule and oriented in the joint substantially in line with the plane of the facet joint articulating surfaces.


In one embodiment, the upper and lower parallel planar surfaces define a thickness that allows the tip to bend while being delivered into the facet from an angle out of alignment with the plane of the facet joint articulating surfaces.


In another embodiment, lower planar surface provides a platform for guiding a second instrument through the aperture for treatment of the facet joint.


The thickness may be generally sized to be smaller than the distance between the first and second boundaries of a facet cavity, and to dispose the tip to bending under light to moderate pressure. The apparatus may have a beveled surface emanating from the upper surface at a point proximal from a leading edge of the tip and extending proximally away from the leading edge.


In one embodiment, the handle comprises a shaft extending from the distal end to the proximal end, the shaft having a beveled surface emanating from the upper surface and terminating at a proximal location toward the handle. The lower planar surface may extend beyond the proximal location to create a platform for guiding a second instrument to the aperture and introducing the second instrument into the cavity.


The second instrument may comprise a rasp configured to decorticate at least one of the articulating surfaces, a distracter for distracting the articulating surfaces, an injector for delivering an agent into the cavity, or an introducer for delivering an implant into the cavity. The tip may function as a platform configured to receive an expandable implant and deliver the implant to a location within the cavity.


Another aspect of an embodiment is an apparatus for distracting two adjacent vertebrae, the being vertebrae separated by a facet joint comprising first and second articulating subchondral surfaces forming a facet cavity enclosed by a facet capsule. The apparatus may include an elongate handle having a proximal end and a distal end; and a wedge detachably disposed at the distal end of the handle. The wedge may have upper and lower beveled surfaces that converge toward a distal tip of the wedge, and is sized to be delivered into the cavity through an aperture in the capsule so that the upper and lower beveled surfaces contact the first and second articulating subchondral surfaces and distract the surfaces as the wedge is driven into the cavity.


In one embodiment, the wedge may comprise a recess on a proximal end of the wedge for detachably coupling the wedge to the handle.


In another embodiment, the apparatus may further include a shaft extending from the distal end of the handle proximal to the wedge. The wedge may be detachably coupled to the shaft. In one embodiment, the shaft may have a planar surface leading from the handle to the wedge to provide a platform for guiding the wedge in cooperation with a second instrument through the aperture.


Generally, the upper and lower beveled surfaces extend proximally from the distal tip to parallel upper and lower distraction surfaces, wherein the distraction surfaces are distanced from each other by a distraction thickness. The distraction thickness may correlate to a desired distraction of the articulating surfaces of the facet joint.


In another embodiment, wherein the wedge comprises one of a plurality of detachable wedges, with each of the detachable wedges having an increasingly larger distraction thickness such that the plurality of detachable wedges may be delivered to the facet joint in series from thinnest to thickest to incrementally distract the facet joint.


In a preferred embodiment, the upper and lower beveled surfaces converge to a nipple located at the distal end of the wedge, wherein the nipple is sized to be inserted in the cavity between the articulating surfaces.


Another aspect of an embodiment is an apparatus for distracting two adjacent vertebrae, having an elongate handle with a proximal end and a distal end, and upper and lower reciprocating members disposed at the distal end of the handle. The upper and lower reciprocating members may be coupled to the handle via a hinge located between proximal and distal ends of the upper and lower reciprocating members. The distal ends of the upper and lower reciprocating members may extend past the distal end of the handle such that the distal ends of the upper and lower reciprocating members may be pressed together to create a smaller profile for entry into the facet capsule and in between the first and second articulating subchondral surfaces. The entry into the facet capsule may result in extension of the proximal ends of the upper and lower reciprocating members away from the handle, wherein the proximal ends of the upper and lower reciprocating members are configured be articulated toward the handle, the hinge acting as a fulcrum to separate the distal ends of the upper and lower reciprocating members and distract the first and second articulating subchondral surfaces.


Generally, the distal ends of the upper and lower reciprocating members may be sized to be delivered into the facet cavity through an aperture in the facet capsule.


In one embodiment, the handle may comprise a hollow tube, with a shaft running through the tube to the distal end of the handle, and a rasp coupled to the shaft at the distal end of the handle, wherein the shaft may be reciprocated within the tube such that the rasp runs along a subchondral surface to decorticate the surface.


Another aspect of an embodiment is an introducer for delivering an implant to an interior region of a facet joint, comprising an elongate handle having a proximal end and a distal end, and a spatula-shaped tip disposed at the distal end of the handle, the tip comprising upper and lower parallel planar surface extending distally outward from the distal end of the handle. The tip may be sized to be delivered into the facet joint via an aperture in the joint capsule and oriented in the joint substantially in line with the plane of the facet joint articulating surfaces, and comprises a platform configured to receive the implant and deliver the implant to a location within the cavity.


In one embodiment, the implant may comprise an inflatable membrane with a pocket configured to slide over the distal tip of the introducer. In this case, the introducer has a delivery line extending from the proximal end of the handle to distal tip and being configured to dispense an inflation medium to the inflatable membrane.


Another aspect of an embodiment is an apparatus for delivering an agent to an interior region of a facet joint, having an elongate handle with a proximal end and a distal end, and a shaft extending from the distal end of the handle. The shaft has a beveled surface at its distal tip, and a delivery line extending from the proximal end of the handle to the distal tip of the shaft. The beveled distal tip of the shaft may be sized to be delivered into the facet joint via an aperture in the joint capsule and oriented in the joint to deliver the agent to a treatment location within the joint. A blade may also be included on the distal end of the shaft, the blade configured to facilitate access into the facet joint.


In one embodiment of the current aspect, the shaft may comprise a lower planar surface extending proximally from the distal tip, wherein the lower planar surface provides a platform for guiding the apparatus in cooperation with a second instrument through the aperture.


Another aspect of an embodiment is a surgical system for treating the facet joint, comprising a first apparatus configured to gain access to the joint. The first apparatus may have an elongate handle having a proximal end and a distal end, and spatula-shaped tip disposed at the distal end of the handle, the tip comprising upper and lower parallel planar surface extending distally outward from the distal end of the handle. The tip may be sized to be delivered into the facet joint via an aperture in the joint capsule and oriented in the joint substantially in line with the plane of the facet joint articulating surfaces. The lower planar surface may provide a platform for guiding a second instrument through the aperture for treatment of the facet joint. The second instrument may comprise a planar surface that is configured to mate with the planar surface of the first instrument and slide distally along the first instrument to into the facet joint.


Another aspect of an embodiment is a system for facet joint immobilization, comprising: a facet access blade configured to pierce through the facet capsule and into the facet cavity to generate a slit-shaped aperture in the facet capsule that extends substantially parallel to the first and second articulating subchondral surfaces. The system may include a distraction apparatus configured to be delivered through the facet capsule and into the facet cavity to distract the first and second articulating subchondral surfaces a predetermined distance, and a decortication apparatus configured to be delivered through the facet capsule and into the facet cavity to decorticate at least one of the first and second articulating subchondral surfaces a predetermined distance. An introducer may also be delivered through the facet capsule and into the facet cavity to deliver an implant between the first and second articulating subchondral surfaces to immobilize the joint at the predetermined distance.


Another aspect of an embodiment is a method for accessing the facet joint of a patient, comprising: delivering a cutting blade to the facet joint capsule; and piercing through the facet capsule and into the facet cavity with the cutting blade to generate a slit-shaped aperture in the facet capsule, the aperture being oriented and sized to accommodate access into the facet joint


The method may further include delivering an introducer through the aperture and into the facet cavity. The cutting blade may be configured to guide delivery of the introducer.


Another aspect of an embodiment is a method for accessing the facet joint of a patient, comprising: delivering a first apparatus configured to gain access to the joint. The first apparatus comprising an elongate handle having a proximal end and a distal end, and a spatula-shaped tip disposed at the distal end of the handle, the tip comprising upper and lower parallel planar surface extending distally outward from the distal end of the handle. The tip is sized to be delivered into the facet joint via an aperture in the joint capsule and oriented in the joint substantially in line with the plane of the facet joint articulating surfaces. A second apparatus is delivered by guiding the second apparatus along the lower planar surface of the first apparatus and through the aperture for treatment of the facet joint. The second apparatus may have a planar surface that is configured to mate with the planar surface of the first apparatus and slide distally along the first apparatus to into the facet joint.


Yet another aspect of an embodiment is a method for immobilizing the facet joint of a patient; comprising delivering a cutting blade to the facet joint capsule; piercing through the facet capsule and into the facet cavity with the cutting blade to generate an aperture in the facet capsule accessing the joint with an introducer; preparing the joint by sanding down cortical bone with a rasp; wherein the rasp is configured to be non-invasively inserted within the aperture created by the cutter; and delivering a distraction device into the facet cavity and distracting the first and second articulating subchondral surfaces.


In one embodiment, the introducer facilitates delivery of the rasp and distraction device.


In one embodiment, the distraction device comprises a wedge detachably disposed at the distal end of an elongate handle, with the method further including delivering the wedge into the cavity through an aperture in the capsule so that the wedge contacts the first and second articulating subchondral surfaces and distract the surfaces as the wedge is driven into the cavity.


In another embodiment, the distraction device comprises an inflatable membrane, and distracting the first and second articulating subchondral surfaces comprises inflating the membrane.


In yet another embodiment, the distraction device comprises a reciprocating introducer, and distracting the first and second articulating subchondral surfaces comprises inserting the introducer into the facet joint and articulating a pair of distal reciprocating members.


Further aspects of the invention will be brought out in the following portions of the specification, wherein the detailed description is for the purpose of fully disclosing preferred embodiments of the invention without placing limitations thereon.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention will be more fully understood by reference to the following drawings which are for illustrative purposes only:



FIG. 1 is a lateral view of two cervical vertebral members in a stenosed condition.



FIG. 2 is a view of a traditional introducer needle being inserted into the facet joint of the vertebral members.



FIGS. 3A-3H include several views of a facet access tool according to certain embodiments.



FIG. 4 is a schematic lateral view of the facet access tool of FIGS. 3A-3H positioned at the facet joint capsule of two cervical vertebral members.



FIG. 5 is a schematic lateral view of the facet access tool of FIGS. 3A-3H piercing and being manipulated within the facet joint capsule, according to certain embodiments.



FIG. 6 is another view of the of the facet access tool of FIGS. 3A-3H piercing the facet joint capsule, according to certain embodiments.



FIG. 7 is a view of the slit-shaped aperture created by the facet access tool of FIGS. 3A-3H.



FIGS. 8A-8H include several views of a facet introducer, according to certain embodiments.



FIG. 9 is a schematic lateral view of the introducer tool of FIGS. 8A-8H being manipulated within the facet joint capsule, according to certain embodiments.



FIG. 10 is a schematic lateral view of the facet blade being used to guide the introducer tool of FIGS. 8A-8H into the joint capsule, according to certain embodiments.



FIGS. 11A-11I include several views of a facet distraction device, according to certain embodiments.



FIGS. 12A-H include several views of a detachable wedge used with the facet distraction device of FIGS. 11A-11I.



FIGS. 13A-13G include several views of an alternative facet distraction device, according to certain embodiments.



FIGS. 14A-14I include several views of a facet decortication tool, according to certain embodiments.



FIGS. 15A-15G include several views of a facet delivery tool for delivering an injectable biomaterial, according to certain embodiments.



FIGS. 16A-16I include several views of a facet inflatable membrane introducer, according to certain embodiments.





DETAILED DESCRIPTION OF THE INVENTION

The present application hereby incorporates the following U.S. patent applications by reference herein in their entireties: U.S. patent application Ser. No. 11/618,619, which was filed on Dec. 29, 2006 and is entitled Cervical Distraction Device; U.S. Provisional Patent Application No. 61/020,082, which was filed on Jan. 9, 2008 and is entitled Methods and Apparatus for Accessing and Treating the Facet Joint; U.S. Provisional Application No. 61/059,723, which was filed on Jun. 6, 2008 and is entitled Spine Distraction Device; U.S. Provisional Application No. 61/097,103, which was filed on Sep. 15, 2008 and is entitled Cervical Distraction/Implant Delivery Device; and U.S. Provisional Application No. 61/109,776, which was filed on Oct. 30, 2008 and is entitled Facet Joint Implants.


Referring more specifically to the drawings, for illustrative purposes, one embodiment of an apparatus is generally shown in FIG. 3A through FIG. 16. It will be appreciated that the apparatus may vary as to configuration and as to details of the parts, and that the method may vary as to the specific steps and sequence, without departing from the basic concepts as disclosed herein.



FIG. 1 illustrates a simplified lateral view of a portion of the cervical spine 10. The basic biomechanical unit or motion segment of the spine consists of two adjacent vertebrae 12 and 14 and the three joint articular complex through which they move and are constrained in relation to one another. The spine articulations generally consist of an intervertebral disc 26 located between the vertebral bodies 26 of adjacent vertebrae 12, 14, and two facet joints 16 symmetrically located laterally from the sagittal plane at the posterior end of the vertebral bodies 26.


The facet joints 16 allow constrained spinal motion, while protecting the contained neural structures. From a kinematic viewpoint, the intervertebral facet joints 16 are highly constrained sliding planar articulations, lubricated by synovial fluid contained within the facet joint capsule 30. In the cervical spine, the geometry of the cervical vertebral bodies provides a high degree of protection for the neural elements by limiting normal motion of the spine to within physiologic limits. The upward inclination of the superior articular surfaces of the facet joints allows for considerable flexion and extension, as well as for lateral mobility.


The distraction, preparation and delivery devices disclosed herein facilitate minimally invasive or percutaneous surgical access, distraction and implant delivery to the facet joint, which is advantageous due to reduced surgical time, reduced recovery time, and improved surgical outcome. Each vertebral segment comprises a spinous process 34 located at the posterior end of the vertebrae, with the vertebral body located anteriorly. Each vertebra comprises an inferior articular (or transverse) process 35 and the superior articular process 37 that form four posterior articulating, e.g. opposing subchondral, surfaces: two superior facets 18 and two inferior facets 16. The inferior facet 18 from the inferior articular process 35 of the upper vertebra 12 and the superior facet from the superior articular process 37 of the lower vertebra 14 form the facet joint 16 on each lateral side of the spine.


Located medial to the articular processes 37 and vertebral bodies 26 is an aperture, or intervertebral foramina 38, that serves as a nerve root canal for the spinal nerves and vessels that transmit signals from the spinal chord to respective locations in the body.


Each facet joint 16 is covered by a dense, elastic articular capsule 28, which is attached just beyond the margins of the articular facets 18, 22. The inside of the capsule is lined by a synovial membrane (not shown), which secretes synovial fluid for lubricating the facet joint. The exterior of the joint capsule is surrounded by a capsular ligament (not shown), which may be temporarily repositioned to give access for insertion of the extendable implant of the present invention, described in further detail below. Thus, from a posterior-lateral approach, access to the facet joint 16 is relatively straightforward and well prescribed, as compared to other regions of the spine, which present a higher likelihood of trauma and risk of permanent damage.


It should also be noted that FIG. 1 depicts cervical foraminal stenosis, e.g. loss of height between the adjacent vertebrae 12, 14. As a result of disc 36 herniation and corresponding height loss, the nerve root canal 38, or intervertebral foraminal height, having a value Hs, is narrowed relative to that of healthy anatomy. This narrowing of the foraminal height Hs often leads to compression of the spinal cord and nerve roots (not shown), causing radicular symptoms.


As a result of the stenosed foraminal height Hs, the height of the facet joint 16, or distance between subchondral articulating surfaces 18 and 22, is also narrowed, (shown as value Ds in FIG. 1). This may pose complications in the facet joint 16 as well. However, because the height of the disc will be relatively fixed, an increase in the facet joint height will also have a corresponding increase in foraminal height, as described in greater detail below.



FIG. 2 illustrates a typical procedure for accessing the facet joint using a standard discography introducer needle 44 to access the facet joint. Because the gap or cavity 30 bound between subchondral articulating surfaces 18 and 22 is generally planar, the cylindrical needle 44 may be difficult to navigate into the capsule 30. Generally precise alignment and orientation of the needle 44 with the subchondral surface 18 and 22 may be used for the needle to enter the cavity 30. Thus, the shape and size constraints of the facet joint 16 make typical cylindrical needles 44 difficult to predictably and consistently gain access to the facet joint capsule.



FIGS. 3A-16 show a system and method of the present invention for performing a minimally invasive procedure configured to distract one or more of the facet joints 16 of vertebrae 12, 14, thereby increasing the dimension of the neural foramen while retaining facet joint mobility. One of the major advantages of minimally invasive surgery is the ability to perform the procedure with minimal tissue trauma. Television image intensifier fluoroscopy may be used to provide guidance for surgeon placement of instrumentation and implants precisely to the desired anatomic target in the facet joint 16. The radiographic landmarks are well taught and the relative procedural difficulty of this technique is low.



FIGS. 3A-3H illustrate a facet access tool 100 in accordance with certain embodiments where FIG. 3G is a close-up view ‘A’ of FIG. 3H. Tool 100 comprises an elongate handle having a flat cutting blade 112 on its distal end 102. The blade 112 generally comprises a straight, flat (i.e. planar), leading edge 110 at distal tip 102 that is sharpened to allow for piercing of the facet joint capsule 28. Although the leading edge 110 is shown as a straight-line surface when viewed from above in FIG. 3B, it is appreciated that different shapes may also be utilized, (e.g. arcuate, triangular, etc.)


The blade 110 is coupled to shaft 108 that is received inside a central channel 116 running axially down handle 106. The shaft and blade protrude distally from the handle 106 so that flat surface 114 running along the bottom of the blade 112 is exposed. The flat surface 114 facilitates introduction and cooperation of additional instruments used for the procedure, discussed in further detail below.


The shaft 108 has a beveled surface 118 that terminates at a point on the distal tip 102 of blade 112. As will be described in further detail below, the beveled surface 118 allows the blade 112 to access into the facet joint from sub-optimal angles of entry, and wedge the blade 112 into the joint for treatment.


It is appreciated that blade 112 may be a separable from shaft 108 and joined with an adhesive, fastener or other securing means. Alternatively blade 112 and shaft 108 may comprise one contiguous or integral piece of material. The blade and shaft may comprise a hardened metal, such as stainless steel or titanium.


The blade 112 and shaft 108 correspondingly have a D-shaped cross-section. Accordingly, chamber 116 of handle 106 also has a D-shaped cross-section, and is sized to receive shaft 108 and blade 112 with a snug fit. Handle 106 may comprise a plastic or similar polymer that is extruded, molded, or heat-shrunk in shape.



FIG. 4 illustrates lateral views of facet access tool 100 positioned at the facet joint 16. According to the method of the present invention, the blade 112 is positioned at the desired location facet joint capsule 28 and then pushed into the capsule to generate an opening 32. FIG. 5 shows the access tool 100 manipulated in the facet cavity 30 through the opening 32 in the capsule wall 28.



FIGS. 6 and 7 illustrate a postero-lateral view of the incision created by the access tool. As seen in FIG. 7 a slit-like opening 32 is generated that runs generally parallel to the facet joint articular surfaces 18, 22.


Once we have gained access to the facet joint cavity 30 with the cutting blade of the facet access tool 100, an introducer 150 may be inserted into the joint. The introducer is shown in FIGS. 8A-8H where 8G is a close-up view ‘A’ of FIG. 8D. The introducer 150, illustrated in FIG. 8, comprises a handle164 at its proximal end, and a malleable “spatula” shaped tip 154 at its distal end 152.


The tip 154 generally comprises a straight, flat leading edge 110 at distal end 152. Although the leading edge 152 is shown as a straight-line surface when viewed from above in FIG. 8A, it is appreciated that different shapes may also be utilized, (e.g. arcuate, triangular, etc.)


The tip 154 is coupled to shaft 158 that is received within a D-shaped opening channel 168 of the handle 156. The shaft 158 and tip 154 protrude distally from the handle 156 so that flat surface 160 running along the bottom of the tip and shaft is exposed. The shaft 158 has a beveled surface 162 that terminates at a point proximal to the distal tip end 152 of tip 154.


The malleable and thin planar shape of the “spatula” tip 154 and beveled shaft 158 allow for suboptimal entry angles and compensates for the narrow spacing of the facet joint. In the method of the present invention, the tip 154 is inserted into the opening 32 created by the facet access tool 100. The flat, thin cross-section of tip 154 is configured to easily slide into thin, planar cavity 30 of the facet joint 30.


As shown in FIG. 9, the tip 154 of introducer is malleable so that it bends into the cavity 30 if introduced from a sub optimal angle. This, along with the beveled surface 162, allows the blade introducer 150 to access into the facet joint from sub-optimal angles of entry, and wedge or manipulate the introducer 150 into the proper orientation in the joint 16 for treatment.


The introducer 150 may be inserted into the cavity 30 after the access blade 100 has been removed, or may be inserted while the access blade 100 is still in place, essentially using the access blade to guide the introducer 150 by sliding the flat bottom surface 160 along the bottom surface 114 of the access blade, as shown in FIG. 10.


In a similar fashion as illustrated in FIG. 10 with the access blade 100, the flat tip 154 of the introducer is also configured to provide a point of entry for later devices used in the surgical method of the present invention, e.g. to enable distraction, decortication, decompression, and fusion of the facet joint 16.


With proper access and orientation of the instruments in the facet joint 16, the articular surfaces 18 and 22 may be distracted to increase the distance Ds. Distraction of the joint 16 may be accomplished via a number of methods, including use of an inflatable membrane such as that disclosed in U.S. patent application Ser. No. 11/618,619 filed on Dec. 29 2006, herein incorporated by reference in its entirety.


Referring now to FIGS. 11A-11I where FIG. 11C is a close-up view ‘A’ of FIG. 11E, FIG. 11 F is a close-up view ‘B’ of FIG. 11G, and FIG. 11D is a close-up view ‘C’ of FIG. 11I and also referring to 12A-12H where FIG. 12G is a cross-sectional view ‘D-D’ of FIG. 12F, distraction may be achieved via a wedge-inserter 170. The wedge inserter 170 comprises an elongate handle 178 at its proximal end 180 and detachable wedge-shaped tip 172 disposed on shaft 174 that is encased, at least proximally, within the handle 178.


The detachable tip 172, further illustrated in FIGS. 12A-12H, converges to a nipple 176 at the distal extremity via beveled surfaces 182 and lateral arcuate surfaces 184. The detachable tip 172 has a keyed receiving hole 186 for attaching the tip 172 to the shaft 174.


The upper and lower beveled surfaces 182 converge to nipple 176 from a box shaped platform defined by lower and upper parallel distraction surfaces 188, and 190. The distance between the lower and upper distraction surfaces 188, and 190 sets the thickness T of the wedge.


The inserter 170 may be directed into to the facet joint cavity 30 with guidance from sliding it along introducer 150. When inserted into the cavity 30, the inserter generates an outward compressive force on the subchondral surfaces 18 and 22 to increase the distance between them to a desired treatment or nominal value DT. As shown in FIGS. 12B-12D, a set of tips 192, 194 and 196, all having a different thickness T, may be used in series so that the joint is progressively distracted. The final thickness T will correspond to the treatment or nominal value DT.


This distraction of walls 18 and 22 correspondingly increases the height of the intervertebral foramin to a treatment or nominal value HT. The value of DT, and resulting increase in HT may be predetermined by the surgeon prior to the surgery based on pre-op analysis of the patient's condition and anatomy, and/or may also be iteratively devised by patient feedback of symptom improvement during the procedure.


Referring now to FIGS. 13A-13G where FIG. 13E is a close-up view ‘B’ of FIG. 13F, distraction may also be achieved via duck-billed distraction device 200. The duckbill comprises an upper pivoting member 204 and lower pivoting member 202 mounted to a tube 214 at hinge 206. A rasp 208 is mounted on shaft 220 that is slideably received within the tube 214.


The distal tips 210 of the pivoting members 202, 204 are configured to collapse down over rasp 208 to facilitate entry of the duckbill into the facet joint cavity 30. Correspondingly, the proximal ends 212 of the pivoting members 202, 204 expand outward from tube 214. Once properly positioned within the cavity 30, the proximal ends of the pivoting members 202, 204 (which are in an expanded configuration), can be manually pressed inward toward the shaft 214. This activation causes the duckbill to expand at distal tips 210, and distract the facet joint 16.


With the facet joint surfaces 18, 22 distracted, the rasp 232 may be articulated distally outward from the duckbill and on to the facet surfaces 18, 22. The rasp 208 may be reciprocated back and forth within the tube 214 (via manual manipulation of the proximal end of shaft 220), thereby decorticating (by sanding or grating the surface) the surfaces in preparation for fusion.



FIGS. 14A-14I illustrate a standalone decorticator 230 where FIG. 14I is a close-up view ‘A’ of FIG. 14H and FIG. 14G is a close-up view ‘B’ of FIG. 14E. Decorticator 230 comprises a flat, flexible spatula-shaped rasp 232 at its distal end 236. The rasp 232 is coupled to shaft 238 that is received inside a central channel running axially down handle 246. The shaft and rasp protrude distally from the handle 246 so that flat surface 242 running along the bottom of the rasp 232 is exposed. The flat surface 242 facilitates introduction and cooperation with the introducer 150 described above.


The shaft 238 has a beveled surface 240 that terminates at a point proximal to the distal tip 236 of the rasp 232. The thin, flexible shape allows the rasp to bend and access into the facet joint from sub-optimal angles of entry. The rasp may have one or more surfaces comprise a plurality of teeth 234 configured to grate down the hard cortical surface of the opposing facet joint surfaces 18, 22.


Alternative decorticating devices may include a flat device with an aggressive cutting surface that is rolled to achieve roughening of the facet surface (not shown), and a device with two opposing rasp surfaces that articulate in a lateral motion through a “scissor like” activation feature. In such a configuration, the two blades of the scissors have flat upper and lower roughened surfaces that would simultaneously decorticate the opposing subchondral surfaces by remote manipulation of the blades. In other embodiments, decorticating devices may take the form of an abraded shaft and decorticating may be performed by rolling the device. In yet other embodiments, decorticating device may take the form of a file mechanism and decorticating may be performed with a back and forth filing motion, where the decorticating device is positioned and actuated using floss.


With the facet joint 16 distracted and decorticated, the method of the present invention includes an embodiment where a specifically shaped piece of structural bone allograft (not shown) is then inserted into the space of distraction between the opposing facet joint surfaces. The bone allograft may be one of a series or kit of bone allograft having a predetermined shape and size (e.g. be sized in thickness that vary by small increments). The bone allograft may then be further shaped by the physician to have a custom size and shape correlating to the specific anatomy of the patient to be treated.


The bone allograft is further supplemented with an injectable biomaterial such as bone morphogenic protein (BMP) to supplement the fusion potential at this level. FIGS. 15A-15G illustrate an injection device 260 for injecting BMP or like substances in accordance with the present invention where FIG. 15G is a close-up view ‘A’ of FIG. 15F. In some embodiments, the injectable biomaterial is used alone without a bone allograft. In either case, the injectable biomaterial may take the form of BMP as mentioned or other injectable biomaterials such as, but not limited to OP1, bonegraft, stem cells, bone cement (PMMA), or other injectable biomaterials now known or later developed.


Device 260 includes an elongate handle 268 having a flat cutting blade 264 on its distal end 262. The blade 264 generally comprises a straight, flat (i.e. planar), leading edge at distal tip 262. Although the leading edge 262 is shown as a straight-line surface when viewed from above in FIG. 15C, it is appreciated that different shapes may also be utilized, (e.g. arcuate, triangular, etc.)


The blade 264 is coupled to shaft 272 that is received inside a central channel running axially down handle 268. The shaft and blade protrude distally from the handle 268 so that flat surface 266 running along the bottom of the blade 262 is exposed. The flat surface 266 facilitates introduction and cooperation with additional instruments such as introducer 150.


The shaft 272 has a beveled surface 274 that terminates at a point on the distal tip 262 of blade 264. The beveled surface 274 allows the blade 112 to access into the facet joint from sub-optimal angles of entry, and wedge the blade into the joint for treatment.


The blade 264 and shaft 272 correspondingly have a D-shaped cross-section. Accordingly, the chamber of handle 268 also has a D-shaped cross-section, and is sized to receive shaft 272 and blade 264 with a snug fit.


The shaft has one or more channels 276 that run axially down the length of the shaft to deliver an injectable biomaterial from lines 280 located at the proximal end 270 of handle 268 to the distal tip 262 of the device. Thus, with the distal tip 262 positioned in the facet joint cavity 230, bmp is delivered though channels 276 to distal tip 262 at the treatment site.


Distraction may also be accomplished via insertion of an inflatable membrane in the joint 16. FIGS. 16A-16I illustrate an insertion device 300 for inserting inflatable membrane 302 into the facet joint in accordance with the present invention where FIG. 16H is a close-up view ‘A’ of FIG. 16G and FIG. 16D is a close-up view ‘B’ of FIG. 16B.


The insertion device 300 comprises a handle 316 at its proximal end 318, and a malleable “spatula” shaped tip 306 at its distal end 308.


The tip 306 generally comprises a straight, flat leading edge at distal end 308. Although the leading edge 308 is shown as a straight-line surface when viewed from above in FIG. 16A, it is appreciated that different shapes may also be utilized, (e.g. arcuate).


The tip 306 is coupled to shaft 310 that is received within a D-shaped opening channel of the handle 316. The shaft 310 and tip 306 protrude distally from the handle 316 so that flat surface 314 running along the bottom of the tip and shaft is exposed. The shaft 310 has a beveled surface 312 that terminates at a point proximal to the distal tip end 308 of tip 306.


Inflatable membrane 302, in accordance with the present invention, has a pocket 304 such that the inflatable membrane 302 can be disposed on distal end 308, and delivered through opening 32 created by the access tool 100 and into the cavity 30. Delivery into the cavity may be guided by sliding lower surface 314 along introducer 150. Once the inflatable membrane 302 is positioned in the proper location within cavity 30, inflation medium is delivered through line 330 running axially along shaft 310 from proximal end 318 to distal tip 308, and the inflatable membrane 302 is expanded inside the joint 30. The inflatable membrane 302 generates a force on the opposing facet surfaces and distracts the joint. With the added pressure, the insertion device 300 is simply just pulled out of the joint, with the tip 306 sliding out of pocket 304 while the inflatable membrane 302 retains its position.


The malleable and thin planar shape of the “spatula” tip 306 and beveled shaft 312 allow for suboptimal entry angles and compensates for the narrow spacing of the facet joint. Thus, the inflatable membrane 302 may be delivered from a less invasive, by non-aligned orientation.


The delivered implant is configured to distract the joint and reverse narrowing of the nerve root canal 38 and alleviate symptoms of cervical stenosis. However, it is also within the scope of the present invention to size the implant according to other spinal conditions, for example to correct for cervical kyphosis or loss of cervical lordosis


The process for achieving indirect cervical decompression and fusion may also include posterior stabilization with any number of commercially available implants & instrument sets available in the art.


Although the embodiments disclosed above are directed primarily to installation in the cervical facet joint, it is contemplated that the devices and methods may also be used to increase foraminal dimension in other regions of the spine, e.g. thoracic, lumbar, etc.


Although the description above contains many details, these should not be construed as limiting the scope of the invention but as merely providing illustrations of some of the presently preferred embodiments of this invention. Therefore, it will be appreciated that the scope of the present invention fully encompasses other embodiments which may become obvious to those skilled in the art, and that the scope of the present invention is accordingly to be limited by nothing other than the appended claims, in which reference to an element in the singular is not intended to mean “one and only one” unless explicitly so stated, but rather “one or more.” All structural, chemical, and functional equivalents to the elements of the above-described preferred embodiment that are known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the present claims. Moreover, it is not necessary for a device or method to address each and every problem sought to be solved by the present invention, for it to be encompassed by the present claims. Furthermore, no element, component, or method step in the present disclosure is intended to be dedicated to the public regardless of whether the element, component, or method step is explicitly recited in the claims. No claim element herein is to be construed under the provisions of 35 U.S.C. 112, sixth paragraph, unless the element is expressly recited using the phrase “means for.”

Claims
  • 1. A surgical system for facet joint immobilization, the facet joint comprising first and second articulating subchondral surfaces forming a facet cavity enclosed by a facet capsule, the surgical system comprising: a facet access tool configured to pierce through the facet capsule and into the facet cavity to generate a minimally invasive slit-shaped aperture in the facet capsule, the facet access tool comprising: a blade sized and shaped to pierce through the facet capsule; anda shaft attached to the blade and including a distal beveled surface sized and shaped to allow the blade to access the facet joint;a distraction apparatus, comprising: an elongate tube;an upper pivoting member mounted to the tube via a hinge; anda lower pivoting member mounted to the tube via the hinge,wherein distal tips of the pivoting members are configured to be delivered through the minimally invasive slit-shaped aperture in the facet capsule and into the facet cavity, and wherein proximal ends of the pivoting members are configured to be manually pressed inward toward the elongate tube to cause the distraction apparatus to expand at the distal tips to distract the first and second articulating subchondral surfaces of the facet joint a predetermined distance;a decortication apparatus slidably received within the tube of the distraction apparatus and configured to be articulated outward from the distal tips and reciprocated back and forth within the tube to decorticate at least one of the first and second articulating subchondral surfaces; andan introducer consisting of: only one, single, elongate shaft configured for insertion through the tube of the distraction apparatus, the shaft comprising: a proximal end; anda distal end opposite the proximal end; anda single tip extending distally outward from the distal end of the single elongate shaft,wherein the introducer is configured to be delivered through the minimally invasive slit-shaped aperture in the facet capsule and into the facet cavity to deliver an implant between the first and second articulating subchondral surfaces of the facet joint to immobilize the joint at said predetermined distance.
  • 2. The surgical system as recited in claim 1, wherein the decortication apparatus comprises: a flat, flexible, spatula-shaped rasp configured to decorticate at least one of the articulating surfaces; anda shaft attached to the rasp and having a distal, beveled surface.
  • 3. The surgical system as recited in claim 1, wherein the implant comprises bone allograft.
  • 4. The surgical system as recited in claim 1, further comprising a delivery system configured to deliver an agent to the facet joint.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims priority to U.S. Provisional Patent Application No. 61/020,082, which was filed on Jan. 9, 2008 and is entitled Methods and Apparatus for Accessing and Treating the Facet Joint. The content of the above-mentioned provisional patent application is hereby incorporated by reference herein in its entirety.

US Referenced Citations (352)
Number Name Date Kind
2708376 Hodgson May 1955 A
2984241 Carlson May 1961 A
4479491 Martin Oct 1984 A
4530355 Griggs Jul 1985 A
4772287 Ray et al. Sep 1988 A
4877020 Vich Oct 1989 A
4878915 Brantigan Nov 1989 A
5015247 Michelson May 1991 A
5026373 Ray et al. Jun 1991 A
5100405 McLaren Mar 1992 A
5135528 Winston Aug 1992 A
5236460 Barber Aug 1993 A
5484437 Michelson Jan 1996 A
5489307 Kuslich et al. Feb 1996 A
5505732 Michelson Apr 1996 A
5527312 Ray Jun 1996 A
5549679 Kuslich Aug 1996 A
5554191 Lahille et al. Sep 1996 A
5571191 Fitz Nov 1996 A
5593409 Michelson Jan 1997 A
5632747 Scarborough et al. May 1997 A
5653763 Errico et al. Aug 1997 A
5665122 Kambin Sep 1997 A
5674295 Ray et al. Oct 1997 A
5720748 Kuslich et al. Feb 1998 A
5741253 Michelson Apr 1998 A
5772661 Michelson Jun 1998 A
5792044 Foley et al. Aug 1998 A
5797909 Michelson Aug 1998 A
5836948 Zuckerman et al. Nov 1998 A
5879353 Terry Mar 1999 A
5885299 Winslow et al. Mar 1999 A
5891147 Moskovitz et al. Apr 1999 A
5895426 Scarborough et al. Apr 1999 A
5899908 Kuslich et al. May 1999 A
5928238 Scarborough et al. Jul 1999 A
5953820 Vasudeva Sep 1999 A
5961522 Mehdizadeh Oct 1999 A
5976146 Ogawa et al. Nov 1999 A
6008433 Stone Dec 1999 A
6033405 Winslow et al. Mar 2000 A
6045580 Scarborough et al. Apr 2000 A
6063088 Winslow May 2000 A
RE36758 Fitz Jun 2000 E
6080155 Michelson Jun 2000 A
6090143 Meriwether et al. Jul 2000 A
6096038 Michelson Aug 2000 A
6099531 Bonutti Aug 2000 A
6102950 Vaccaro Aug 2000 A
6149650 Michelson Nov 2000 A
RE37005 Michelson et al. Dec 2000 E
6159245 Meriwether et al. Dec 2000 A
6176882 Biedermann et al. Jan 2001 B1
6190388 Michelson et al. Feb 2001 B1
6190414 Young et al. Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6210412 Michelson Apr 2001 B1
RE37161 Michelson et al. May 2001 E
6224595 Michelson May 2001 B1
6224607 Michelson May 2001 B1
6224630 Bao et al. May 2001 B1
6248110 Reiley et al. Jun 2001 B1
D444878 Walter Jul 2001 S
D445188 Walter Jul 2001 S
6264656 Michelson Jul 2001 B1
6267763 Castro Jul 2001 B1
6270498 Michelson Aug 2001 B1
6283966 Houfburg Sep 2001 B1
6315795 Scarborough et al. Nov 2001 B1
6371984 Van Dyke et al. Apr 2002 B1
6402784 Wardlaw Jun 2002 B1
6423063 Bonutti Jul 2002 B1
6423083 Reiley et al. Jul 2002 B2
6425919 Lambrecht Jul 2002 B1
6436098 Michelson Aug 2002 B1
6436142 Paes et al. Aug 2002 B1
6443988 Felt et al. Sep 2002 B2
6451023 Salazar et al. Sep 2002 B1
6454807 Jackson Sep 2002 B1
6478796 Zucherman et al. Nov 2002 B2
6500206 Bryan Dec 2002 B1
6514256 Zucherman et al. Feb 2003 B2
6558390 Cragg May 2003 B2
6565574 Michelson May 2003 B2
6569186 Winters et al. May 2003 B1
6575919 Reiley et al. Jun 2003 B1
6579319 Goble et al. Jun 2003 B2
6582432 Michelson Jun 2003 B1
6607530 Carl et al. Aug 2003 B1
6610091 Reiley Aug 2003 B1
6626905 Schmiel et al. Sep 2003 B1
6632235 Weikel et al. Oct 2003 B2
6635060 Hanson et al. Oct 2003 B2
6641582 Hanson et al. Nov 2003 B1
6648893 Dudasik Nov 2003 B2
6652584 Michelson Nov 2003 B2
6663647 Reiley et al. Dec 2003 B2
6666866 Martz et al. Dec 2003 B2
6679886 Weikel et al. Jan 2004 B2
6682535 Hoogland Jan 2004 B2
6685742 Jackson Feb 2004 B1
6709458 Michelson Mar 2004 B2
6712853 Kuslich Mar 2004 B2
6719773 Boucher et al. Apr 2004 B1
6723095 Hammerslag Apr 2004 B2
6740093 Hochschuler et al. May 2004 B2
6751875 Jones Jun 2004 B2
6770074 Michelson Aug 2004 B2
6793679 Michelson Sep 2004 B2
6805715 Reuter et al. Oct 2004 B2
6808537 Michelson Oct 2004 B2
6823871 Schmieding Nov 2004 B2
6840941 Rogers et al. Jan 2005 B2
6875213 Michelson Apr 2005 B2
6899719 Reiley et al. May 2005 B2
6921403 Cragg et al. Jul 2005 B2
6923813 Phillips et al. Aug 2005 B2
6962606 Michelson Nov 2005 B2
6966930 Arnin et al. Nov 2005 B2
6972035 Michelson Dec 2005 B2
6979333 Hammerslag Dec 2005 B2
6986772 Michelson Jan 2006 B2
7001385 Bonutti Feb 2006 B2
7008453 Michelson Mar 2006 B1
7033362 McGahan et al. Apr 2006 B2
7033392 Schmiel et al. Apr 2006 B2
7066961 Michelson Jun 2006 B2
D524443 Blain Jul 2006 S
7083623 Michelson Aug 2006 B2
7096972 Orozco Aug 2006 B2
7101398 Dooris et al. Sep 2006 B2
7115128 Michelson Oct 2006 B2
7118598 Michelson Oct 2006 B2
7128760 Michelson Oct 2006 B2
7175023 Martin Feb 2007 B2
7179263 Zdeblick et al. Feb 2007 B2
7207991 Michelson Apr 2007 B2
D541940 Blain May 2007 S
7264622 Michelson Sep 2007 B2
7288093 Michelson Oct 2007 B2
7291149 Michelson Nov 2007 B1
7300440 Zdeblick et al. Nov 2007 B2
7326211 Padget et al. Feb 2008 B2
7326214 Michelson Feb 2008 B2
7371238 Soboleski et al. May 2008 B2
7399303 Michelson Jul 2008 B2
7410501 Michelson Aug 2008 B2
7431722 Michelson Oct 2008 B1
7445636 Michelson Nov 2008 B2
7452359 Michelson Nov 2008 B1
7452369 Barry Nov 2008 B2
7465304 Haufe et al. Dec 2008 B1
7476251 Zucherman et al. Jan 2009 B2
7479160 Branch et al. Jan 2009 B2
7491205 Michelson Feb 2009 B1
7500992 Li Mar 2009 B2
7569054 Michelson Aug 2009 B2
7648523 Mirkovic et al. Jan 2010 B2
D611147 Hanson et al. Mar 2010 S
7686807 Padget et al. Mar 2010 B2
7708761 Petersen May 2010 B2
D627468 Richter et al. Nov 2010 S
7824431 McCormack Nov 2010 B2
7850733 Baynham et al. Dec 2010 B2
7879098 Simmons Feb 2011 B1
7892261 Bonutti Feb 2011 B2
7988714 Puekert et al. Aug 2011 B2
8062303 Berry et al. Nov 2011 B2
8162981 Vestgaarden Apr 2012 B2
8267966 McCormack et al. Sep 2012 B2
8361152 McCormack et al. Jan 2013 B2
8425558 McCormack et al. Apr 2013 B2
8512347 McCormack et al. Aug 2013 B2
20010004710 Felt et al. Jun 2001 A1
20020026195 Layne et al. Feb 2002 A1
20020107519 Dixon Aug 2002 A1
20020143343 Castro Oct 2002 A1
20020147496 Belef et al. Oct 2002 A1
20020147497 Belef et al. Oct 2002 A1
20020165612 Gerber et al. Nov 2002 A1
20020169471 Ferdinand Nov 2002 A1
20030028251 Mathews Feb 2003 A1
20030033017 Lotz et al. Feb 2003 A1
20030105526 Bryant et al. Jun 2003 A1
20030109928 Pasquet et al. Jun 2003 A1
20030139816 Michelson Jul 2003 A1
20030144737 Sherman Jul 2003 A1
20030158553 Michelson Aug 2003 A1
20030158557 Cragg et al. Aug 2003 A1
20030199983 Michelson Oct 2003 A1
20030225416 Bonvallet et al. Dec 2003 A1
20040059337 Hanson et al. Mar 2004 A1
20040073217 Michelson Apr 2004 A1
20040087948 Suddaby May 2004 A1
20040087956 Weikel et al. May 2004 A1
20040093084 Michelson May 2004 A1
20040106999 Mathews Jun 2004 A1
20040133208 Weikel et al. Jul 2004 A1
20040133277 Michelson Jul 2004 A1
20040133280 Trieu Jul 2004 A1
20040148029 Bianchi et al. Jul 2004 A1
20040162562 Martz Aug 2004 A1
20040215344 Hochschuler et al. Oct 2004 A1
20040236331 Michelson Nov 2004 A1
20050010294 Michelson Jan 2005 A1
20050015149 Michelson Jan 2005 A1
20050027358 Suddaby Feb 2005 A1
20050049705 Hale et al. Mar 2005 A1
20050055096 Serhan et al. Mar 2005 A1
20050060037 Michelson Mar 2005 A1
20050065518 Michelson Mar 2005 A1
20050065519 Michelson Mar 2005 A1
20050065529 Liu et al. Mar 2005 A1
20050065608 Michelson Mar 2005 A1
20050065609 Wardlaw Mar 2005 A1
20050080422 Otte et al. Apr 2005 A1
20050090829 Martz et al. Apr 2005 A1
20050090901 Studer Apr 2005 A1
20050113929 Cragg et al. May 2005 A1
20050119660 Bourlion et al. Jun 2005 A1
20050119680 Dykes Jun 2005 A1
20050124993 Chappuis Jun 2005 A1
20050154460 Yundt Jul 2005 A1
20050159650 Raymond et al. Jul 2005 A1
20050159746 Grob et al. Jul 2005 A1
20050177240 Blain Aug 2005 A1
20050182417 Pagano Aug 2005 A1
20050216018 Sennett Sep 2005 A1
20050240188 Chow et al. Oct 2005 A1
20050251146 Martz et al. Nov 2005 A1
20050251257 Mitchell et al. Nov 2005 A1
20050261695 Cragg et al. Nov 2005 A1
20050267480 Suddaby Dec 2005 A1
20060004367 Alamin et al. Jan 2006 A1
20060015184 Winterbottom et al. Jan 2006 A1
20060036243 Sasso et al. Feb 2006 A1
20060036247 Michelson Feb 2006 A1
20060036323 Carl et al. Feb 2006 A1
20060041311 McLeer Feb 2006 A1
20060058793 Michelson Mar 2006 A1
20060058878 Michelson Mar 2006 A1
20060064099 Pavlov et al. Mar 2006 A1
20060064100 Bertagnoli et al. Mar 2006 A1
20060069442 Michelson Mar 2006 A1
20060079905 Beyar et al. Apr 2006 A1
20060079962 Michelson Apr 2006 A1
20060084992 Michelson Apr 2006 A1
20060085068 Barry Apr 2006 A1
20060085074 Raiszadeh Apr 2006 A1
20060095028 Bleich May 2006 A1
20060095036 Hammerslag May 2006 A1
20060111779 Peterson May 2006 A1
20060111780 Petersen May 2006 A1
20060111781 Petersen May 2006 A1
20060111782 Peterson May 2006 A1
20060142762 Michelson Jun 2006 A1
20060149239 Winslow et al. Jul 2006 A1
20060149254 Lauryssen et al. Jul 2006 A1
20060149272 Winslow et al. Jul 2006 A1
20060149289 Winslow et al. Jul 2006 A1
20060149373 Winslow et al. Jul 2006 A1
20060149374 Winslow et al. Jul 2006 A1
20060184172 Michelson Aug 2006 A1
20060190081 Kraus et al. Aug 2006 A1
20060195109 McGahan et al. Aug 2006 A1
20060200137 Soboleski et al. Sep 2006 A1
20060200138 Michelson Sep 2006 A1
20060200139 Michelson Sep 2006 A1
20060200164 Michelson Sep 2006 A1
20060206118 Kim et al. Sep 2006 A1
20060217812 Lambrecht et al. Sep 2006 A1
20060229625 Truckai et al. Oct 2006 A1
20060235387 Peterman Oct 2006 A1
20060235391 Sutterlin, III Oct 2006 A1
20060241597 Mitchell et al. Oct 2006 A1
20060241626 McGahan et al. Oct 2006 A1
20060241758 Peterman et al. Oct 2006 A1
20060247632 Winslow et al. Nov 2006 A1
20060247633 Winslow et al. Nov 2006 A1
20060247650 Yerby et al. Nov 2006 A1
20060259142 Dooris et al. Nov 2006 A1
20060271195 Thramann Nov 2006 A1
20060276790 Dawson et al. Dec 2006 A1
20060276801 Yerby et al. Dec 2006 A1
20060276897 Winslow et al. Dec 2006 A1
20070016195 Winslow et al. Jan 2007 A1
20070016196 Winslow et al. Jan 2007 A1
20070016218 Winslow et al. Jan 2007 A1
20070032871 Michelson Feb 2007 A1
20070043362 Malandain et al. Feb 2007 A1
20070055245 Sasso et al. Mar 2007 A1
20070055263 Way et al. Mar 2007 A1
20070073402 Vresilovic et al. Mar 2007 A1
20070083265 Malone Apr 2007 A1
20070123863 Winslow et al. May 2007 A1
20070123888 Bleich et al. May 2007 A1
20070135814 Farris Jun 2007 A1
20070135921 Park Jun 2007 A1
20070149976 Hale et al. Jun 2007 A1
20070149983 Link Jun 2007 A1
20070150061 Trieu Jun 2007 A1
20070161991 Altarac et al. Jul 2007 A1
20070179617 Brown et al. Aug 2007 A1
20070179619 Grob et al. Aug 2007 A1
20070225721 Thelen et al. Sep 2007 A1
20070244483 Winslow et al. Oct 2007 A9
20070276491 Ahrens Nov 2007 A1
20070288014 Shadduck et al. Dec 2007 A1
20070299451 Tulkis Dec 2007 A1
20080021457 Anderson et al. Jan 2008 A1
20080108996 Padget et al. May 2008 A1
20080140207 Olmos et al. Jun 2008 A1
20080161810 Melkent Jul 2008 A1
20080161929 McCormack et al. Jul 2008 A1
20080167657 Greenhalgh Jul 2008 A1
20080177311 Winslow et al. Jul 2008 A1
20080208341 McCormack et al. Aug 2008 A1
20080216846 Levin Sep 2008 A1
20080234758 Fisher et al. Sep 2008 A1
20080255564 Michelson Oct 2008 A1
20080255618 Fisher et al. Oct 2008 A1
20080255622 Mickiewicz et al. Oct 2008 A1
20080255666 Fisher et al. Oct 2008 A1
20080255667 Horton Oct 2008 A1
20080287955 Michelson Nov 2008 A1
20080312744 Vresilovic et al. Dec 2008 A1
20090131986 Lee et al. May 2009 A1
20090138053 Assell et al. May 2009 A1
20090234397 Petersen Sep 2009 A1
20090306671 McCormack et al. Dec 2009 A1
20090312763 McCormack et al. Dec 2009 A1
20100069912 McCormack et al. Mar 2010 A1
20100086185 Weiss Apr 2010 A1
20100093829 Gorman Apr 2010 A1
20110009968 McCormack Jan 2011 A1
20110022089 Assell et al. Jan 2011 A1
20110082548 Assell et al. Apr 2011 A1
20120143334 Boyce et al. Jun 2012 A1
20130006364 McCormack et al. Jan 2013 A1
20130012994 McCormack et al. Jan 2013 A1
20130013070 McCormack et al. Jan 2013 A1
20130018474 McCormack et al. Jan 2013 A1
20130023995 McCormack et al. Jan 2013 A1
20130023996 McCormack et al. Jan 2013 A1
20130030440 McCormack et al. Jan 2013 A1
20130030532 McCormack et al. Jan 2013 A1
20130110168 McCormack et al. May 2013 A1
20130123922 McCormack et al. May 2013 A1
20130144389 Bonutti Jun 2013 A1
20130310839 McCormack et al. Nov 2013 A1
20130310878 McCormack et al. Nov 2013 A1
20130310943 McCormack et al. Nov 2013 A1
Foreign Referenced Citations (14)
Number Date Country
G 93 04 368.6 May 2003 DE
2 722 980 Feb 1996 FR
WO 9949818 Oct 1999 WO
WO 0035388 Jun 2000 WO
WO 0053126 Sep 2000 WO
WO 0101895 Jan 2001 WO
WO 0234120 May 2002 WO
WO 0238062 May 2002 WO
WO 02076335 Oct 2002 WO
WO 2006058221 Jun 2006 WO
WO 2006130791 Dec 2006 WO
WO 2009148619 Dec 2009 WO
WO 2010030994 Mar 2010 WO
WO 2010074714 Jul 2010 WO
Non-Patent Literature Citations (112)
Entry
US 7,063,700, 06/2006, Michelson (withdrawn)
International Search Report and Written Opinion, International patent application No. PCT/US2009/030461, dated Aug. 17, 2009.
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee, and Partial International Search Report, International patent application No. PCT/US2009/056841, dated Dec. 10, 2009.
International Search Report and Written Opinion, International patent application No. PCT/US2009/003423, dated Dec. 14, 2009.
Final Office Action, U.S. Appl. No. 12/110,548, mailed Feb. 26, 2010, 4 pages.
International Search Report and Written Opinion, International patent application No. PCT/US2007/089146, dated Nov. 3, 2008.
International Search Report and Written Opinion, International patent application No. PCT/US2009/056841, dated Apr. 9, 2010.
International Search Report and Written Opinion, International patent application No. PCT/US2009/006478, dated Jun. 29, 2010.
Press Release, Interventional Spine, Inc., FDA Grants Conditional Approval to Interventional Spine's PercuDyn™ System IDE Application (Jul. 1, 2008).
Press Release, Interventional Spine, Inc., Interventional Spine, Inc. Introduces the PERPOS® Fusion Facet Prep Kit (Oct. 14, 2008).
Press Release, minSURG Corp., Orthopedic Development Corporation's TruFUSE® Procedure Tops 1,750 Patients in First Year (Sep. 24, 2007).
Notice of Allowance, U.S. Appl. No. 12/110,548, mailed Mar. 29, 2010, 5 pages.
Notice of Allowance, U.S. Appl. No. 12/110,548, mailed Jul. 14, 2010, 10 pages.
Amendment and Response to Non-Final Office Action, U.S. Appl. No. 12/110,548, filed May 5, 2009, 11 pages.
Annex to Form PCT/ISA/206 Communication Relating to the Results of the Partial International Search and p. 1 of the Invitation to Pay Additional Fees, International patent application No. PCT/US2009/030461, dated May 13, 2009, 3 pages.
Office Action Restriction, U.S. Appl. No. 12/317,682, dated Apr. 22, 2011, 14 pages.
Office Action Restriction, U.S. Appl. No. 12/455,814, dated Apr. 20, 2011, 14 pages.
Office Action Restriction, U.S. Appl. No. 12/653,283, dated Jun. 24, 2011, 9 pages.
Response to Restriction, U.S. Appl. No. 12/317,682, filed May 16, 2011, 15 pages.
Response to Restriction, U.S. Appl. No. 12/455,814, filed May 16, 2011, 10 pages.
Response to Restriction, U.S. Appl. No. 12/653,283, filed Jul. 22, 2011, 8 pages.
Goel, Atul et al., Facetal Distraction as Treatment for Single- and Multilevel Cervical Spondylotic Radiculopathy and Myelopathy: A Preliminary Report, J Neurosurg Spine 14:689-696, Jun. 2011; published online Mar. 18, 2011; DOI: 10.3171/2011.2.SPINE10601.
Annex to Form PCT/ISA/206 Communication Relating to the Results of the Partial International Search and p. 1 of the Invitation to Pay Additional Fees, International patent application No. PCT/US2009/003423, dated Sep. 14, 2009, 3 pages.
Non-Final Office Action, U.S. Appl. No. 12/653,283, dated Aug. 9, 2011, 20 pages.
Non-Final Office Action and PTO-892, U.S. Appl. No. 11/618,619, mailed Jan. 3, 2008. 12.
Interview summary, U.S. Appl. No. 11/618,619, mailed Mar. 18, 2008, 3 pages.
Amendment, U.S. Appl. No. 11/618,619, filed May 5, 2008, 10 pages.
Final Office Action, U.S. Appl. No. 11/618,619, mailed Aug. 8, 2008, 10 pages.
Non-Final Office action and PTO-892, U.S. Appl. No. 12/110,548, mailed Feb. 17, 2009, 11.
Corrected Response to Restriction Requirement, U.S. Appl. No. 12/317,682, filed Sep. 2, 2011, 15 pages.
Final Office Action, U.S. Appl. No. 12/317,682, mailed Feb. 10, 2012, 8 pages.
Non-Final Office Action, U.S. Appl. No. 12/317,682, dated Sep. 15, 2011, 25 pages.
Non-Final Office Action, U.S. Appl. No. 12/455,814, dated Jan. 24, 2012, 30 pages.
Non-Final Office Action, U.S. Appl. No. 12/653,283, mailed Feb. 10, 2012, 7 pages.
Notice of Non-Responsive Amendment, U.S. Appl. No. 12/317,682, dated Aug. 8, 2011, 2 pages.
Office Action (Quayle), U.S. Appl. No. 12/653,283, dated Dec. 22, 2011, 8 pages.
Response to Non-Final Office Action, U.S. Appl. No. 12/317,682, filed Dec. 13, 2011, 19 pages.
Response to Non-Final Office Action, U.S. Appl. No. 12/653,283, filed Dec. 6, 2011, 14 pages.
Response to Quayle Action, U.S. Appl. No. 12/653,283, filed Feb. 1, 2012, 3 pages.
Advisory Action, U.S. Appl. No. 12/317,682, dated Apr. 6, 2012, 3 pages.
Final Office Action, U.S. Appl. No. 12/653,283, mailed Mar. 21, 2012, 8 pages.
Non-Final Office Action, U.S. Appl. No. 12/889,122, dated Mar. 29, 2012, 20 pages.
Notice of Allowance, U.S. Appl. No. 12/317,682, mailed May 11, 2012, 10 pages.
Response to Advisory Action, U.S. Appl. No. 12/317,682, filed Apr. 24, 2012, 4 pages.
Response to Final Office Action, U.S. Appl. No. 12/317,682, filed Mar. 22, 2012, 17 pages.
Response to Non-Final Office Action, U.S. Appl. No. 12/455,814, filed Apr. 24, 2012, 15 pages.
Response to Non-Final Office Action, U.S. Appl. No. 12/653,283, filed Mar. 8, 2012, 9 pages.
Restriction Requirement, U.S. Appl. No. 12/559,193, dated Apr. 18, 2012, 10 pages.
Final Office Action, U.S. Appl. No. 12/455,814, mailed Jun. 6, 2012, 12 pages.
Non-Final Office Action, U.S. Appl. No. 12/653,283, mailed Jul. 18, 2012, 5 pages.
Response to Final Office Action, U.S. Appl. No. 12/653,283, filed Jun. 15, 2012, 7 pages.
Response to Non-Final Office Action and Terminal Disclaimer, U.S. Appl. No. 12/889,122, filed Jun. 27, 2012, 8 pages.
Response to Restriction, U.S. Appl. No. 12/559,193, filed Jul. 17, 2012, 6 pages.
U.S. Appl. No. 29/435,381, filed Oct. 23, 2012, McCormack et al.
U.S. Appl. No. 29/435,385, filed Oct. 23, 2012, McCormack et al.
U.S. Appl. No. 29/448,474, filed Mar. 12, 2013, McCormack et al.
U.S. Appl. No. 29/448,467, filed Mar. 12, 2013, McCormack et al.
U.S. Appl. No. 14/037,164, filed Sep. 25, 2013, McCormack et al.
U.S. Appl. No. 14/037,198, filed Sep. 25, 2013, McCormack et al.
Advisory Action, U.S. Appl. No. 12/455,814, dated Aug. 16, 2012, 3 pages.
Final Office Action, U.S. Appl. No. 12/559,193, mailed Feb. 13, 2013, 10 pages.
Final Office Action, U.S. Appl. No. 12/653,283, mailed Nov. 19, 2012, 8 pages.
Final Office Action, U.S. Appl. No. 13/614,372, dated Oct. 25, 2013, 9 pages.
Final Office Action, U.S. Appl. No. 13/614,508, dated Dec. 23, 2013, 12 pages.
Final Office Action, U.S. Appl. No. 13/627,825, dated Dec. 4, 2013, 8 pgs.
Final Office Action, U.S. Appl. No. 13/627,850, dated Dec. 30, 2013, 12 pages.
Final Office Action, U.S. Appl. No. 13/627,865, dated Dec. 4, 2013, 10 pages.
Non-Final Office Action, U.S. Appl. No. 29/435,381, dated Oct. 7, 2013, 20 pages.
Non-Final Office Action, U.S. Appl. No. 12/559,193, mailed Sep. 18, 2012, 26 pages.
Non-Final Office Action, U.S. Appl. No. 13/614,372, mailed Jun. 26, 2013, 22 pages.
Non-Final Office Action, U.S. Appl. No. 13/614,508, mailed Jul. 17, 2013, 25 pages.
Non-Final Office Action, U.S. Appl. No. 13/614,577, mailed Jul. 19, 2013, 22 pages.
Non-Final Office Action, U.S. Appl. No. 13/614,577, dated Dec. 5, 2013, 10 pages.
Non-Final Office Action, U.S. Appl. No. 13/627,825, mailed Jul. 19, 2013, 22 pages.
Non-Final Office Action, U.S. Appl. No. 13/627,850, mailed Jul. 25, 2013, 23 pages.
Non-Final Office Action, U.S. Appl. No. 13/627,865, mailed Jul. 26, 2013, 25 pages.
Non-Final Office Action, U.S. Appl. No. 13/722,802, mailed Sep. 26, 2013, 8 pages.
Non-Final Office Action, U.S. Appl. No. 29/435,385, dated Oct. 2, 2013, 20 pages.
Non-Final Office Action, U.S. Appl. No. 29/448,467, dated Oct. 2, 2013, 8 pages.
Non-Final Office Action, U.S. Appl. No. 29/448,474, dated Oct. 2, 2013, 8 pages.
Notice of Allowance, U.S. Appl. No. 12/455,814, mailed Oct. 2, 2012, 6 pages.
Notice of Allowance, U.S. Appl. No. 12/559,193, mailed Apr. 22, 2013, 8 pages.
Notice of Allowance, U.S. Appl. No. 12/653,283, mailed Feb. 28, 2013, 10 pages.
Notice of Allowance, U.S. Appl. No. 12/889,122, mailed Sep. 25, 2012, 7 pages.
Notice of Allowance, U.S. Appl. No. 13/627,812, mailed Aug. 30, 2013, 25 pages.
Response to Advisory Action, U.S. Appl. No. 12/455,814, filed Sep. 5, 2012, 6 pages.
Response to Final Office Action, U.S. Appl. No. 12/455,814, filed Aug. 6, 2012, 13 pages.
Response to Final Office Action, U.S. Appl. No. 12/559,193, filed Apr. 12, 2013, 8 pages.
Response to Final Office Action, U.S. Appl. No. 12/653,283, filed Feb. 19, 2013, 5 pages.
Response to Final Office Action, U.S. Appl. No. 13/614,372, dated Dec. 20, 2013, 11 pages.
Response to Non-Final Office Action and Terminal Disclaimer, U.S. Appl. No. 13/627,850, filed Oct. 25, 2013, 11 pages.
Response to Non-Final Office Action, U.S. Appl. No. 12/559,193, filed Dec. 13, 2012, 7 pages.
Response to Non-Final Office Action, U.S. Appl. No. 12/653,283, filed Oct. 18, 2012, 6 pages.
Response to Non-Final Office Action, U.S. Appl. No. 13/614,372, filed Sep. 26, 2013, 13 pages.
Response to Non-Final Office Action, U.S. Appl. No. 13/614,508, filed Oct. 17, 2013, 12 pages.
Response to Non-final Office Action, U.S. Appl. No. 13/614,577, filed Oct. 21, 2013, 10 pages.
Response to Non-Final Office Action, U.S. Appl. No. 13/627,825, filed Oct. 21, 2013, 11 pages.
Response to Non-Final Office Action, U.S. Appl. No. 13/627,865, dated Oct. 28, 2013, 17 pages.
Response to Restriction, U.S. Appl. No. 13/614,372, filed May 16, 2013, 6 pages.
Response to Restriction, U.S. Appl. No. 13/614,508, filed Jun. 1, 2013, 6 pages.
Response to Restriction, U.S. Appl. No. 13/614,577, filed Jun. 1, 2013, 6 pages.
Response to Restriction, U.S. Appl. No. 13/627,812, filed Aug. 7, 2013, 6 pages.
Response to Restriction, U.S. Appl. No. 13/627,825, filed Jun. 1, 2013, 6 pages.
Response to Restriction, U.S. Appl. No. 13/627,850, filed Jun. 1, 2013, 5 pages.
Response to Restriction, U.S. Appl. No. 13/627,865, filed Jun. 1, 2013, 6 pages.
Restriction Requirement, U.S. Appl. No. 13/614,372, mailed Apr. 17, 2013, 6 pages.
Restriction Requirement, U.S. Appl. No. 13/614,508, mailed May 3, 2013, 6 pages.
Restriction Requirement, U.S. Appl. No. 13/614,577, mailed May 2, 2013, 6 pages.
Restriction Requirement, U.S. Appl. No. 13/627,812, mailed Jul. 16, 2013, 7 pages.
Restriction Requirement, U.S. Appl. No. 13/627,825, mailed May 2, 2013, 7 pages.
Restriction Requirement, U.S. Appl. No. 13/627,850, mailed May 2, 2013, 7 pages.
Restriction Requirement, U.S. Appl. No. 13/627,865, mailed May 6, 2013, 5 pages.
Related Publications (1)
Number Date Country
20090177205 A1 Jul 2009 US
Provisional Applications (1)
Number Date Country
61020082 Jan 2008 US